| Literature DB >> 34279658 |
Xiao Li1, Jing-Nan Ren1, Gang Fan1, Lu-Lu Zhang2, Si-Yi Pan1.
Abstract
(+)-Nootkatone is an important functional sesquiterpene and is comprehensively used in pharmaceutical, cosmetic, agricultural and food flavor industries. However, (+)-nootkatone is accumulated trace amounts in plants, and the demand for industry is mainly met by chemical methods which is harmful to the environment. The oxygen-containing sesquiterpenes prepared using microbial methods can be considered as "natural." Microbial transformation has the advantages of mild reaction conditions, high efficiency, environmental protection, and strong stereoselectivity, and has become an important method for the production of natural spices. The microbial biosynthesis of (+)-nootkatone from the main precursor (+)-valencene is summarized in this paper. Whole-cell systems of fungi, bacteria, microalgae, and plant cells have been employed. It was described that the enzymes involved in the microbial biosynthesis of (+)-nootkatone, including cytochrome p450 enzymes, laccase, lipoxygenase, and so on. More recently, the related enzymes were expressed in microbial hosts to heterologous produce (+)-nootkatone, such as Escherichia coli, Pichia pastoris, Yarrowia lipolytica, and Saccharomyces cerevisiae. Finally, the development direction of research for realizing industrialization of microbial transformation was summarized and it provided many options for future improved bioprocesses.Entities:
Keywords: (+)-Nootkatone; (+)-Valencene; Biosynthesis; Natural flavor; Nootkatol
Mesh:
Substances:
Year: 2021 PMID: 34279658 PMCID: PMC8788795 DOI: 10.1093/jimb/kuab046
Source DB: PubMed Journal: J Ind Microbiol Biotechnol ISSN: 1367-5435 Impact factor: 4.258
Fig. 1.(a) Conversion of (+)-valencene to (+)-nootkatone via nootkatol. 1: (+)-Valencene; 2: nootkatol (β-nootkatol and α-nootkatol); 3: (+)-nootkatone. (b) Transformation of (+)-valencene to (+)-nootkatone by laccase via valencene-2-hydroperoxide (Fraatz et al., 2009). It was followed by a subsequent degradation step by heating or addition of chemical catalysts. 1: (+)-Valencene; 2: valencene-2-hydroperoxide; 3: (+)-nootkatone. (c) Transformation of (+)-valencene to (+)-nootkatone by (+)-valencene dioxygenase from P. sapidus via (+)-valencene hydroperoxides [2,2′,3,3′] (Krugener et al., 2010). [1] (+)-Valencene; [2] 2(R)-isopropenyl-8(R),8a(S)-dimethyl-1,3,4,7,8,8a-hexahydro-2H-naphthalen-4a(R)-yl-hydroperoxide; [2′] 2(R)-isopropenyl-8(R),8a(S)-dimethyl-1,3,4,7,8,8a-hexahydro-2H-naphthalen-4a(S)-yl-hydroperoxide; [3] 6(R)-isopropenyl-4(R),4a(S)-dimethyl-2,3,4,4a,5,6,7,8-octahydro-naphthalen-2(S)-yl-hydroperoxide; [3′] 6(R)-isopropenyl-4(R),4a(S)-dimethyl-2,3,4,4a,5,6,7,8-octahydro-naphthalen-2(R)-yl-hydroperoxide; [4] β-Nootkatol; [4′] α-nootkatol; [5] nootkatone.
Microbial Biotransformation of (+)-Valencene to (+)-Nootkatone
| Strain | Time | Nootkatone (maximum yield) | References |
|---|---|---|---|
|
| |||
|
| / | / | Willershausen & Graf ( |
|
| 2 days | 1296 mg/l | Huang et al. ( |
|
| 7 days | 82% (328 mg/l) | Asakawa et al. ( |
|
| 7 days | 84% (336 mg/l) | Asakawa et al. ( |
|
| 7 days | 42% (168 mg/l) | Asakawa et al. ( |
|
| 3 days | 25 mg/l | Kaspera et al. ( |
| Meng et al. ( | |||
| Lyophilisates of | 13 hr | 250 mg/l | Kaspera ( |
|
| 24 hr | 320 mg/l | Fraatz ( |
| Homogenised fresh mycelium of | 42 hr | 600 mg/l | Fraatz et al. ( |
|
| 12 days | 239.7 ± 2.1 mg/l | Palmerín-Carreño et al. ( |
|
| 12 days | 110.3 ± 11.8 mg/l | Palmerín-Carreño et al. ( |
|
| 12 days | 14.51 ± 0.83 mg/l | Palmerín-Carreño et al. ( |
|
| 12 days | 4.70 ± 0.56 mg/l | Palmerín-Carreño et al. ( |
|
| 12 days | 0.315 ± 0.23 mg/l | Palmerín-Carreño et al. ( |
|
| 4 days | 852.3 mg/l | Palmerin-Carreno, Castillo-Araiza, et al. ( |
|
| |||
|
|
| 12% | Dhavlikar and Albroscheit ( |
|
| 5 days | 0.5 mol% (50 mg/l) | Huang et al. ( |
|
|
| 47% | Sowden et al. ( |
|
|
| 7.7% | Sowden et al. ( |
|
| |||
|
| 18 days | 63% (252 mg/l) | Furusawa et al. ( |
|
| 14 days | 63% (252 mg/l) | Asakawa et al. ( |
|
| 14 days | 80% (320 mg/l) | Asakawa et al. ( |
|
| 14 days | 90% (360 mg/l) | Asakawa et al. ( |
|
| |||
|
| / | trace | Drawert and Berger ( |
|
| 6 hr | 1.1 mg/l | Drawert et al. ( |
|
| / | 2% | Delrio et al. ( |
|
| / | 2% | Delrio et al. ( |
|
| / | 2% | Delrio et al. ( |
|
| 20 days | 72% (650 mg/l) | Sakamaki et al. ( |
| Leonhardt and Berger ( | |||
|
| 20 days | 25% (225 mg/l) | Sakamaki et al. ( |
|
| 20 days | 28% (252 mg/l) | Sakamaki et al. ( |
“/” represent there is no reports in literature.
Enzymes Associated with Microbial Transformation of (+)-Valencene to (+)-Nootkatone
| Enzymes | Origin | Reference |
|---|---|---|
|
| ||
| P450cam |
| Sowden et al. ( |
| P450BM-3 |
| Sowden et al. ( |
| CYP109B1 |
| Girhard et al. ( |
| CYP71D55 (HPO) |
| Gavira et al. ( |
| CYP71AV8 | Chicory | Cankar et al. ( |
| CYP71D51v2 | Tobacco ( | Gavira et al. ( |
| CnVO (CYP706M1) | Alaska cedar ( | Cankar et al. ( |
|
| ||
| Laccase |
| Huang et al. ( |
| Laccase |
| Kolwek et al. ( |
|
| ||
| Lignin peroxidase |
| Willershausen ( |
| Lipoxygenase |
| Fraatz et al. ( |
| Lipoxygenase |
| Omarini et al. ( |
|
| ||
| Alcohol dehydrogenase (ADH-C3) |
| Wriessnegger et al. ( |
| Glucose dehydrogenase (GDH) |
| Schulz et al. ( |
| Alcohol dehydrogenase (ADH1) |
| Ouyang et al. ( |
| Cytochrome P450 reductase (ATR1) |
| Meng et al. ( |
| Short-chain dehydrogenase/reductase (SDR) superfamily dehydrogenases ZSD1 |
| Meng et al. ( |
| Short-chain dehydrogenase/reductase (SDR) superfamily dehydrogenases A2B2 |
| Meng et al. ( |
| Cytochrome P450 reductase (CPR) |
| Cankar et al. ( |
| BMD_2094 |
| Milhim et al. ( |
|
| ||
| Putidaredoxin reductase (PdR) |
| Girhard et al. ( |
Fig. 2.Heterologous synthesis of (+)-nootkatone in yeast (a) and E. coli (b). HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; IPP, isopentenyl pyrophosphate; DMAPP, dimethylallyl pyrophosphate; GPP, geranyl diphosphate; FPP, farnesyl diphosphate; HMGR, HMG-CoA reductase; IDI1, isopentenyl pyrophosphate (IPP) isomerase; ERG20, farnesyl diphosphate synthase; ERG9, squalene synthase enzyme; CnVS, (+)-valencene synthase.
Heterologous Synthesis of (+)-Nootkatone
| Heterologous expression vector | Enzymes | Nootkatone (maximum yield) | References |
|---|---|---|---|
|
| Valencene synthase gene from | / | Chappell and Greenhagen ( |
|
| PdR; putidaredoxin (Pdx); CYP109B1 | 120 mg/l | Girhard et al. ( |
|
| Valencene dioxygenase (ValOx) from | 80 mg/l | Zelena et al. ( |
|
| (+)-Valencene synthase (CnVS); HPO; CPR; alcohol dehydrogenase (ADH) | 208 mg/l | Wriessnegger et al. ( |
|
| CnVS; CYP706M1; codon-optimized NADPH-cytochrome P450 reductase opAtCPR1 | 978.2 μg/l | Guo et al. ( |
|
| CnVS; CYP71AV8; CPR | 0.04 mg/l | Cankar et al. ( |
|
| CYP71D51v2 from tobacco; P450 reductase from | 4 mg/l | Gavira et al. ( |
|
| CnVS; CYP706M1 | 144 ± 10 μg/l | Cankar et al. ( |
|
| (+)-Valencene synthase ValS; tHMG1; HPO; CPR; ICE2 | /31 mg/l (total terpene) | Emmerstorfer et al. ( |
|
| CnVS; HPO; cytochrome P450 reductase from | 53.7 mg/l | Ouyang et al. ( |
|
| CnVS; HPO; ATR1; dehydrogenase/reductase (SDR) ZSD1 | 59.78 mg/l | Meng et al. ( |
“/” represent there is no reports in literature.